Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10142-2-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10142-2-AP, RRID:AB_2168236
- Product name
- PRKAR2A antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated PRKAR2A antibody (Cat. #10142-2-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Nicotine restores olfactory function by activation of prok2R/Akt/FoxO3a axis in Parkinson's disease.
STK25 inhibits PKA signaling by phosphorylating PRKAR1A.
TMT-based proteomics analysis to screen potential biomarkers of acute-phase TBI in rats.
Depletion of LAMP3 enhances PKA-mediated VASP phosphorylation to suppress invasion and metastasis in esophageal squamous cell carcinoma.
Guo Q, Wang Y, Yu L, Guan L, Ji X, Li X, Pang G, Ren Z, Ye L, Cheng H
Journal of translational medicine 2024 Apr 12;22(1):350
Journal of translational medicine 2024 Apr 12;22(1):350
STK25 inhibits PKA signaling by phosphorylating PRKAR1A.
Zhang X, Wang BZ, Kim M, Nash TR, Liu B, Rao J, Lock R, Tamargo M, Soni RK, Belov J, Li E, Vunjak-Novakovic G, Fine B
Cell reports 2022 Aug 16;40(7):111203
Cell reports 2022 Aug 16;40(7):111203
TMT-based proteomics analysis to screen potential biomarkers of acute-phase TBI in rats.
Wang H, Chen J, Gao C, Chen W, Chen G, Zhang M, Luo C, Wang T, Chen X, Tao L
Life sciences 2021 Jan 1;264:118631
Life sciences 2021 Jan 1;264:118631
Depletion of LAMP3 enhances PKA-mediated VASP phosphorylation to suppress invasion and metastasis in esophageal squamous cell carcinoma.
Huang F, Ma G, Zhou X, Zhu X, Yu X, Ding F, Cao X, Liu Z
Cancer letters 2020 Jun 1;479:100-111
Cancer letters 2020 Jun 1;479:100-111
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- K-562 cells were subjected to SDS PAGE followed by western blot with 10142-2-AP(PRKAR2A antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP result of anti-PRKAR2A(10142-2-AP for IP and Detection).
- Sample type
- cell line
